Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT
AP11 Limited's stake in Sagimet Biosciences Inc. - Series A fell to 4.90% (Schedule 13G/A)
Event Jun 24, 2025 · Filed Jun 24, 2025
AP11 Limited's stake in Sagimet Biosciences Inc. - Series A fell to 4.90%, 1,504,642 shares, as a passive investor on Jun 24, 2025. Filed Jun 24, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 1,504,642
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AP11 Limited | 4.90% | 1,504,642 |
| Ascletis Pharma Inc. | 4.90% | 1,504,642 |
Source
Related
- Sagimet Biosciences Inc. - Series A
- AP11 Limited
- Sagimet Biosciences Inc. - Series A shareholders
- Schedule 13G · AP11 Limited · May 20, 2025
- Schedule 13G · Commodore Capital LP · Oct 7, 2026
- Form 4 · Kemble George · Aug 17, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Kemble George · Aug 12, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026